Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Early Mobilization in Ventilated SEpsis & Acute Respiratory Failure Study
Not Applicable
Completed
- Conditions
- Critically IllEarly Mobility
- Interventions
- Other: early mobilization
- First Posted Date
- 2020-10-12
- Last Posted Date
- 2025-01-03
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT04582760
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Effect of Cerebral and Cerebellar rTMS in Stroke Patient
Not Applicable
Completed
- Conditions
- StrokerTMSMotor RecoveryRepetitive Transcranial Magnetic Stimulation
- Interventions
- Procedure: Repetitive transcranial magnetic stimulation
- First Posted Date
- 2020-09-30
- Last Posted Date
- 2024-10-03
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 56
- Registration Number
- NCT04570774
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Mobile Application Using the PRO-CTCAE to Improve Patients' Participation in Symptom Management During Treatment.
Not Applicable
- Conditions
- Neoplasms
- Interventions
- Other: ePRO-CTCAE application
- First Posted Date
- 2020-09-29
- Last Posted Date
- 2021-07-08
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 222
- Registration Number
- NCT04568278
- Locations
- 🇰🇷
Danbee Kang, Seoul, Korea, Republic of
🇰🇷Samsung Medical Center, Seoul, Korea, Republic of
Efficacy and Safety of 80mg Osimertinib in Patients With Non-small Cell Lung Cancer(NSCLC)
Phase 2
Completed
- Conditions
- Non-small Cell Lung Cancer (NSCLC)
- Interventions
- Drug: 80mg Osimertinib
- First Posted Date
- 2020-09-25
- Last Posted Date
- 2024-01-03
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 73
- Registration Number
- NCT04563871
- Locations
- 🇰🇷
ChungBuk National University Hospital, Cheonju, Korea, Republic of
🇰🇷National Cancer Center, Goyang, Korea, Republic of
🇰🇷Seoul National University Bundang Hospital, Seongnam, Korea, Republic of
A Study on Brain Activity During Transcranial Direct Current Stimulation in Stroke Patients
Not Applicable
Completed
- Conditions
- Stroke
- Interventions
- Device: Transcranial direct current simulation
- First Posted Date
- 2020-09-16
- Last Posted Date
- 2021-03-10
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT04549753
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
A Single-arm Study of Gemcitabine, Cisplatin, and Nab-Paclitaxel as Neoadjuvant Therapy for Resectable Oncologically High-Risk IHCC in Korea
Phase 2
Withdrawn
- Conditions
- Intrahepatic Cholangiocarcinoma
- Interventions
- Drug: Gemcitabine, Cisplatin, and Nab-Paclitaxe
- First Posted Date
- 2020-09-14
- Last Posted Date
- 2022-06-15
- Lead Sponsor
- Samsung Medical Center
- Registration Number
- NCT04546828
Effect of Perioperative Bronchodilator in COPD Patients Undergoing Lung Cancer Surgery
Phase 3
- Conditions
- Chronic Obstructive Pulmonary DiseaseNon Small Cell Lung Cancer
- Interventions
- Drug: Placebo
- First Posted Date
- 2020-09-03
- Last Posted Date
- 2021-04-02
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 204
- Registration Number
- NCT04536675
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Efficacy of Exercise Program for Facedown Posture-related Pain After Retinal Surgery
Not Applicable
Completed
- Conditions
- Macular HolesRetinal Detachment
- Interventions
- Behavioral: A structured exercise
- First Posted Date
- 2020-09-02
- Last Posted Date
- 2020-12-16
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 70
- Registration Number
- NCT04535622
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Effectiveness and Safety of an Early Mobilization Protocol in a Pediatric Intensive Care Unit
Not Applicable
Recruiting
- Conditions
- Critical Illness
- Interventions
- Other: Early rehabilitation protocol for children hospitalized in the PICU
- First Posted Date
- 2020-08-24
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 142
- Registration Number
- NCT04524065
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Clinical Relevance of DNMT and HDAC Gene SNP on the Response to Decitabine Therapy for Myelodysplastic Syndrome
Completed
- Conditions
- Myelodysplastic Syndrome
- First Posted Date
- 2020-08-17
- Last Posted Date
- 2020-08-17
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 68
- Registration Number
- NCT04515914
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of